Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 
WhatsApp Image 2020-08-30 at 10.58.51 PM

The Center for Advanced-Applied Biological Sciences &
Entrepreneurship-Journal (TCABSE-J)

Volume 1, Issue 1 of TCABSE-J, April 13th, 2021

ISSN: 2583-2557

CCLicense_edited.jpg

  • TCABSE-J Strategic Communications:

    • Promoting the post COVID-19 alveolar regeneration by targeting cellular signalling pathways through small molecule intervention.

             (Chintalapati, J. & Yedidi, R.S. 2021)

  • TCABSE-J Commentary:

    • Liquid-liquid phase separation-based membraneless organelles: the guardian bubbles of protein life. (Sodasani, M. & Yedidi, R.S. 2021)

  • TCABSE-J Communications:

    • Structural deviations of HIV-1 glycoprotein-120 (gp120) compared to the wild type gp120 explain the failure of passive immunization. (Regani et al. 2021)

  • TCABSE-J Applications Report:

    • Targeting the TIMPs with PROTAC-based small molecules as a potential
      therapeutic approach for Liver cirrhosis treatment. (Buddana et al. 2021)

  • TCABSE-J Analysis Report:

    • Major structural deviations in the receptor binding domain of SARS-CoV-2
      spike protein may pose threat to the existing vaccines. (Vissapragada et al. 2021)

  • TCABSE-J Strategic Communications:

    • HelicoTAC©, a PROTAC-based small molecule targeting the virulence factor Cag A of H. pylori as a potential therapeutic for gastritis and gastric cancer. (Aggunna & Yedidi 2021)

Please contact us at tcabsej@gmail.com with any questions!